Neurology ReviewsOutpatient Visits Involving CNS Polypharmacy Rising Among ElderlyMarch 29, 2017Neuromuscular Disorders
Clinical Neurology NewsLVADs achieve cardiac palliation in muscular dystrophiesMarch 20, 2017Neuromuscular DisordersPediatrics
Clinical Neurology NewsFDA approves Emflaza for Duchenne muscular dystrophyFebruary 9, 2017Neuromuscular DisordersPediatricsRare Diseases
Clinical Neurology NewsNew histopathologic marker may aid dermatomyositis diagnosisJanuary 20, 2017Neuromuscular DisordersRare Diseases
Clinical Neurology NewsMeningococcal conjugate vaccination may be associated with increased risk of Bell’s palsyDecember 26, 2016PediatricsNeuromuscular Disorders
Neurology ReviewsWhat’s New in Rare Neuromuscular Disorders?November 21, 2016Neuromuscular DisordersRare Diseases
Clinical Neurology NewsIs physician-assisted suicide compatible with the Hippocratic Oath?November 9, 2016Neuromuscular DisordersNeuro-oncologyBusiness of Medicine
Neurology ReviewsWhat Are New and Potential Therapies for Neuromuscular Disorders?October 27, 2016Neuromuscular DisordersRare DiseasesPain
Clinical Neurology NewsFurther evidence links Zika, Guillain-Barré syndromeOctober 6, 2016Neuromuscular Disorders
Clinical Neurology NewsIncontinence trial finds small advantage for Botox over sacral neuromodulationOctober 4, 2016Neuromuscular Disorders
Clinical Neurology NewsFDA approves Duchenne muscular dystrophy treatment under ‘accelerated pathway’September 19, 2016PediatricsNeuromuscular DisordersRare Diseases
Clinical Neurology NewsGuillain-Barré incidence rose with Zika across AmericasSeptember 1, 2016Neuromuscular DisordersRare Diseases
Clinical Neurology NewsFDA: New labeling warns against combining opioids, benzodiazepinesAugust 31, 2016Neuromuscular DisordersNeurosurgery & TraumaPainTrauma
